
What happened
CrowdStrike and SailPoint each gained 15% since Monday, Palo Alto Networks rose 10%, Okta added 9%, and the First Trust Nasdaq Cybersecurity ETF gained 5%.
Why it matters
The gains likely reflect expectations that cybersecurity firms will grow faster as companies double down on protecting their infrastructure, per the article.
What to watch
The rally is tied to an AI safety debate — Anthropic's Dario Amodei called for slowing the pace of AI capability improvements, and Salesforce's Marc Benioff said AI must not become 'social media 2.0.'
WHO IT HITSCybersecurity investors and corporate security teams watching AI risk debates now see market momentum shifting toward identity and infrastructure protection vendors.
Summaries like this, in your inbox every morning.
The week's rally ties a familiar pattern — fear driving demand — to a very specific debate about AI. Anthropic CEO Dario Amodei's Sept. 12 essay argued that fully addressing AI risks requires not just investing in risk prevention but pacing the rate of capabilities advancement. OpenAI's Sam Altman agreed, then posted on X days later. Salesforce's Marc Benioff, speaking at Dreamforce, framed the moment as a choice: AI leaders must step up, or AI risks repeating social media's harms.
Against that backdrop, Okta CEO Todd McKinnon described threat actors actively using AI models and organizations scrambling to track identities. That operational reality — attackers adopting the same tools, defenders needing to keep pace — is the body's own link between the warnings and the stock moves.
The rally's durability likely hinges on whether that spending shift into identity and infrastructure protection continues, and on how the safety debate among AI leaders evolves. Investors should watch whether the momentum holds after Friday's slide and whether other cybersecurity names follow the same pattern.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
Applied Clinical Trials Online reports on lessons drawn from hundreds of clinical trials involving AI, coverin…

Co-CEO Clay Magouyrk said Oracle last year hadn't found broad internal use for generative AI; after rolling ou…

At the AWS Global Meeting on September 17, Chief AI and Technology Officer Matt Wood named Trainium for comput…

Twist Bioscience signed an agreement to provide antibody characterization data and services to Eli Lilly's AI/…

A proposed class-action filed November 14, 2023 alleges UnitedHealth and subsidiary NaviHealth used nH Predict…

International Business Machines trades at US$237.75, below its discounted cash flow value, as an investigation…
